Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

A text at the right moment: can it defuse Stress-Led cravings?

NCT ID NCT07746492

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 05, 2026 · Last updated Aug 06, 2026 · Updated 1 time

Summary

This pilot trial tests whether a brief, culturally adapted support message sent to a smartphone during moments of high stress can reduce the urge to smoke, vape, or eat in response to stress. About 115 gender and sexual minority adults in Dhaka will receive up to five check-ins per day over 24 days. When stress levels spike, the app randomly sends either a support message or nothing, and participants rate their urge shortly after. The goal is to see if this just-in-time intervention can ease cravings in real time and whether it can be delivered safely and privately in a high-stigma setting.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Just-in-Time Adaptive Support Message
What this could lead to
If effective, this approach could offer a discreet, on-the-spot tool to help people manage stress-driven urges, potentially reducing smoking and unhealthy eating in high-stigma settings.
What could go wrong
This is a small pilot study, so results may not be conclusive. The effect may be short-lived, and the study does not address the underlying stigma that causes stress.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 115 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Feb 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 18 years or older * Self-identifies as a gender and/or sexual minority person * Resides in Dhaka at enrolment and expects to remain in Dhaka throughout the 24-day assessment period * Reports at least one qualifying behaviour on average at least 3 days per week during the past month: (a) smoking or vaping, or (b) eating primarily in response to stress, anxiety, or emotional distress * Owns a personal Android or iOS smartphone compatible with the study platform that is used solely by the participant and is not shared with others * Able to read, understand, and respond to simple Bangla text * Able to operate the study app independently after a structured onboarding session * Willing to complete five scheduled app-based momentary assessments per day for 24 days and additional brief follow-up assessments after randomized decision points * Provides written informed consent Exclusion Criteria: * Currently participating in another behavioural or pharmacological intervention study targeting smoking, vaping, or eating behaviour * Has a severe or unstable psychiatric condition that, based on screening and review by the study clinician, would make participation in the repeated daily assessment protocol unsafe * Is unable to operate the study app independently after structured onboarding

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Electronic cigarette use are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Coitus Emotional Eating nicotine dependence Smoking Stress, Psychological Tobacco Use Vaping

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b)

    Dhaka, Bangladesh

More trials for these conditions

Other studies related to the condition(s) this trial covers.